Andlauer Healthcare Group 향후 성장

Future 기준 점검 0/6

Andlauer Healthcare Group의 수익이 증가할 것으로 예상됨입니다.

핵심 정보

n/a

이익 성장률

n/a

EPS 성장률

Healthcare 이익 성장	60.6%
매출 성장률	2.8%
향후 자기자본이익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	07 Oct 2025

최근 향후 성장 업데이트

Recent updates

Andlauer Healthcare Group's (TSE:AND) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 20

Andlauer Healthcare Group (TSE:AND) Will Be Hoping To Turn Its Returns On Capital Around

Mar 15

Unpleasant Surprises Could Be In Store For Andlauer Healthcare Group Inc.'s (TSE:AND) Shares

Feb 28

We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Nov 07

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Oct 17

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Sep 20

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

May 23

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Jan 30

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Aug 24

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

May 05

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Oct 28

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Oct 12

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Aug 17

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Jul 19

Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

Jul 05

The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing

May 04

이익 및 매출 성장 예측

TSX:AND - 애널리스트 향후 추정치 및 과거 재무 데이터 (CAD Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
12/31/2027	695	N/A	119	147	2
12/31/2026	679	N/A	102	148	4
12/31/2025	655	N/A	94	132	4
6/30/2025	651	67	99	122	N/A
3/31/2025	655	70	105	124	N/A
12/31/2024	650	64	104	124	N/A
9/30/2024	651	66	103	127	N/A
6/30/2024	648	65	101	125	N/A
3/31/2024	644	65	85	113	N/A
12/31/2023	648	66	79	104	N/A
9/30/2023	645	67	87	116	N/A
6/30/2023	653	71	94	125	N/A
3/31/2023	665	76	102	132	N/A
12/31/2022	648	76	109	137	N/A
9/30/2022	616	110	109	129	N/A
6/30/2022	555	103	98	111	N/A
3/31/2022	493	95	85	97	N/A
12/31/2021	440	90	74	84	N/A
9/30/2021	394	51	54	61	N/A
6/30/2021	365	47	52	59	N/A
3/31/2021	328	41	51	58	N/A
12/31/2020	314	38	46	51	N/A
9/30/2020	304	31	64	72	N/A
6/30/2020	299	30	57	65	N/A
3/31/2020	300	31	54	61	N/A
12/31/2019	290	30	55	61	N/A
9/30/2019	285	28	44	49	N/A
12/31/2018	277	27	N/A	52	N/A
12/31/2017	251	22	N/A	43	N/A
12/31/2016	224	19	N/A	30	N/A

애널리스트 향후 성장 전망

수입 대 저축률: AND 의 예상 수익 증가율이 절약률(2.6%)보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: AND 의 수익이 Canadian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: AND 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: AND 의 수익(연간 2.8%)이 Canadian 시장(연간 4.5%)보다 느리게 성장할 것으로 예상됩니다.

고성장 매출: AND 의 수익(연간 2.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: AND의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/10/10 22:34
종가	2025/10/10 00:00
수익	2025/06/30
연간 수익	2024/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Andlauer Healthcare Group Inc.는 9명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Kevin Chiang	CIBC Capital Markets
Cameron Doerksen	National Bank Financial
Endri Leno	National Bank Financial

Andlauer Healthcare Group 향후 성장

Future 기준 점검 0/6

핵심 정보

최근 향후 성장 업데이트

Price target increased by 13% to CA$54.83

Price target increased to CA$57.83

Recent updates

Second quarter dividend of CA$0.12 announced

Andlauer Healthcare Group Inc. Announces Third Quarter Dividend, Payable on October 15, 2025

Second quarter 2025 earnings released: EPS: CA$0.34 (vs CA$0.38 in 2Q 2024)

First quarter dividend of CA$0.12 announced

Andlauer Healthcare Announces Second Quarter Dividend, Payable on July 15, 2025

First quarter 2025 earnings released: EPS: CA$0.52 (vs CA$0.36 in 1Q 2024)

Price target increased by 13% to CA$54.83

UPS Healthcare entered into a definitive agreement to acquire Andlauer Healthcare Group Inc. (TSX:AND) from Andlauer Management Group Inc. and others for CAD 2.2 billion.

Andlauer Healthcare Group Inc. to Report Q1, 2025 Results on May 01, 2025

Andlauer Healthcare Group's (TSE:AND) Shareholders Will Receive A Bigger Dividend Than Last Year

Fourth quarter dividend of CA$0.12 announced

Andlauer Healthcare Group (TSE:AND) Will Be Hoping To Turn Its Returns On Capital Around

Andlauer Healthcare Announces Dividend for the First Quarter Ended March 31, 2025, Payable on April 15, 2025

Andlauer Healthcare Group Inc. Proposes Quarterly Dividend

Unpleasant Surprises Could Be In Store For Andlauer Healthcare Group Inc.'s (TSE:AND) Shares

Full year 2024 earnings released: EPS: CA$1.60 (vs CA$1.58 in FY 2023)

Andlauer Healthcare Group Inc., Annual General Meeting, May 02, 2025

Andlauer Healthcare Group Announces Executive Changes

Andlauer Healthcare Group Inc. to Report Q4, 2024 Results on Feb 26, 2025

Third quarter dividend of CA$0.11 announced

Andlauer Healthcare Group Inc. Announces Fourth Quarter Shareholder Dividend for the Period from October 1, 2024 to December 31, 2024, Payable on January 15, 2025

Insider recently sold CA$887k worth of stock

We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Third quarter 2024 earnings released: EPS: CA$0.41 (vs CA$0.37 in 3Q 2023)

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Andlauer Healthcare Group Inc. to Report Q3, 2024 Results on Nov 05, 2024

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Second quarter dividend of CA$0.11 announced

Andlauer Healthcare Announces Third Quarter Dividend, Payable on October 15, 2024

President of Specialty Solutions recently sold CA$211k worth of stock

Second quarter 2024 earnings released: EPS: CA$0.38 (vs CA$0.38 in 2Q 2023)

Andlauer Healthcare Group Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chairman of the Board recently sold CA$970k worth of stock

First quarter dividend of CA$0.10 announced

Andlauer Healthcare Announces Second Quarter Dividend, Payable on July 15, 2024

President of Specialty Solutions recently sold CA$791k worth of stock

Chairman of the Board exercised options to buy CA$3.8m worth of stock.

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

Andlauer Healthcare Group Inc. (TSX:AND) announces an Equity Buyback for 2,000,000 shares, representing 4.8% for CAD 90 million.

President of Specialty Solutions exercised options to buy CA$1.3m worth of stock.

First quarter 2024 earnings released: EPS: CA$0.36 (vs CA$0.39 in 1Q 2023)

Andlauer Healthcare Group Inc. to Report Q1, 2024 Results on May 02, 2024

Fourth quarter dividend of CA$0.10 announced

Andlauer Healthcare Group Inc. Provides Quarterly Dividend Guidance

Full year 2023 earnings released: EPS: CA$1.58 (vs CA$1.82 in FY 2022)

Andlauer Healthcare Group Inc., Annual General Meeting, May 03, 2024

Andlauer Healthcare Group Inc. to Report Q4, 2023 Results on Mar 05, 2024

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Andlauer Healthcare Group Inc. Announces Board Changes

Chairman of the Board recently bought CA$768k worth of stock

Chairman of the Board recently sold CA$774k worth of stock

Third quarter 2023 earnings released: EPS: CA$0.37 (vs CA$0.45 in 3Q 2022)

Andlauer Healthcare Group Inc. to Report Q3, 2023 Results on Nov 02, 2023

Upcoming dividend of CA$0.09 per share at 0.8% yield

Andlauer Healthcare Group Inc. Announces the Third Quarter Shareholder Dividend, Payable on October 16, 2023

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Andlauer Healthcare Group Inc. Intends to Declare Quarterly Dividend

Second quarter 2023 earnings released: EPS: CA$0.37 (vs CA$0.50 in 2Q 2022)

Andlauer Healthcare Group Inc. to Report Q2, 2023 Results on Aug 01, 2023

Andlauer Healthcare Group Inc. Announces Dividend for the Second Quarter Period from April 1, 2023 to June 30, 2023, Payable on July 17, 2023

Insider recently sold CA$9.8m worth of stock

Insider recently sold CA$242k worth of stock

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

First quarter 2023 earnings released: EPS: CA$0.39 (vs CA$0.40 in 1Q 2022)

Andlauer Healthcare Group Inc. Appoints Graham Cromb as Chief Strategy Officer

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?

President of Transportation recently sold CA$709k worth of stock

Upcoming dividend of CA$0.08 per share at 0.6% yield

Full year 2022 earnings released: EPS: CA$1.82 (vs CA$2.30 in FY 2021)

Andlauer Healthcare Group Inc., Annual General Meeting, May 04, 2023

Andlauer Healthcare Group Inc. to Report Q4, 2022 Results on Mar 02, 2023